Liver metastasis from hepatoid adenocarcinoma of the esophagus mimicking hepatocellular carcinoma

Alpha-fetoprotein (AFP)-producing adenocarcinoma, histologically mimicking hepatocellular carcinoma (HCC), is a distinct entity known as hepatoid adenocarcinoma (HAC). Reported cases of HAC arising from the esophagus are extremely rare. Due to common liver metastasis and elevated AFP levels in patients with esophageal HAC, differentiation of HAC with liver metastasis from HCC could be challenging. We describe a case of esophageal HAC that presented with a liver mass showing hepatoid features and elevated serum AFP levels. Initial presentation was suspicious for HCC. Upon further diagnostic work-up, the patient was diagnosed with esophageal HAC with liver metastasis. The distinction between these two entities is particularly important because HAC is more aggressive, and its therapeutic options are very limited.

[1]  Chun-Ying Wu,et al.  Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review. , 2013, World journal of gastroenterology.

[2]  T. Kamei,et al.  A Case of Alpha-Fetoprotein-Producing Barrett Esophageal Carcinoma with Different Histological Patterns , 2012 .

[3]  N. Kuroda,et al.  Combined tubular adenocarcinoma and hepatoid adenocarcinoma arising in Barrett esophagus. , 2011, Annals of diagnostic pathology.

[4]  M. Fukayama,et al.  SALL4 Represents Fetal Gut Differentiation of Gastric Cancer, and is Diagnostically Useful in Distinguishing Hepatoid Gastric Carcinoma From Hepatocellular Carcinoma , 2010, The American journal of surgical pathology.

[5]  K. Olden,et al.  Hepatoid Esophageal Carcinoma: a Rare Cause of Elevated Alfa Fetoprotein , 2008, Journal of Gastrointestinal Cancer.

[6]  Hiroyuki Aburatani,et al.  The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma , 2005, Modern Pathology.

[7]  Kazunori Otsuka,et al.  AFP-producing hepatoid adenocarcinoma in association with Barrett's esophagus with multiple liver metastasis responding to paclitaxel/CDDP: a case report. , 2005, Anticancer research.

[8]  T. Oda,et al.  Alpha-fetoprotein Producing Adenocarcinoma of Esophagogastric Junction: A Case Report , 2005 .

[9]  T. Motoyama,et al.  Combined choriocarcinoma, hepatoid adenocarcinoma, small cell carcinoma and tubular adenocarcinoma in the oesophagus , 2004, Virchows Archiv.

[10]  R. Alsabeh,et al.  Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. , 2002, Human pathology.

[11]  K. Saigenji,et al.  Hepatoid adenocarcinoma in Barrett’s esophagus associated with achalasia: First case report , 2002, Pathology international.

[12]  T. Motoyama,et al.  Different characteristics of hepatoid and non‐hepatoid α‐fetoprotein‐producing gastric carcinomas: An experimental study using xenografted tumors , 1994, International journal of cancer.

[13]  T. Morohoshi,et al.  The significance of alpha‐fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours , 1989, Histopathology.

[14]  H. Ishikura,et al.  An AFP‐producing gastric carcinoma with features of hepatic differentiation. A case report , 1985, Cancer.

[15]  A. Fondimare,et al.  [Existence of alpha feto protein during gastric-origin secondary cancer of the liver]. , 1970, La Presse medicale.